Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinoma

Journal of Laboratory and Clinical Medicine

Volumn 127, Issue 6, 1996, Pages 553-564

  Grosley, B M ^b   Hirschauer, C ^b   Chambrette, B ^b   Bezeaud, A ^b   Amiral, J ^a  

^a PAE Parispace 3   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030174550     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90146-8     Document Type: Article

References (36)

1. Stenflo J, Suttie JW. Vitamin K-dependent formation of γ-carboxyglutamic acid. Ann Rev Biochem 1977;46:157-72.
2. Harbeck MC, Cheung AY, Suttie JW. Vitamin K-dependent carboxylase: partial purification of the enzyme by antibody affinity techniques. Thromb Res 1989;56:317-23.
3. Olson RE. The function and metabolism of vitamin K. Ann Rev Nutr 1984;4:281-337.
4. Liebman HA, Furie BC, Tong MJ, et al. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary HCC. N Engl J Med 1984;310:1427-31.
5. Weitz IC, Liebman HA. Des-γ-carboxy (abnormal) prothrombin and HCC: a critical review. Hepatology 1993;18: 990-8.
6. Fujiyama S, Morishita T, Sagara K, Sato T, Motohara K, Matsuda J. Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with HCC. Hepatogastroenterology 1986;33:201-5.
7. Mothohara K, Endo F, Matsuda J, Iwamase F. Acarboxy prothombin (PIVKA-II) as a marker of hepatoblastome in infants. J Pediatr Gastroenterol Nutr 1987;6:42-5.
8. Fujiyama S, Morishita T, Hashiguchi O, Sato T. Plasma abnormal prothrombin (des-γ-carboxy prothrombin) as a marker of HCC. Cancer 1988;61:1621-8.
9. Kasahara A, Hayashi N, Fusamoto H, et al. Clinical evaluation of plasma des-γ-carboxy prothrombin as a marker protein of HCC in patients with tumors of various sizes. Dig Dis Sci 1993;38:2170-6.
10. Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T. Protein induced by vitamin K absence or antagonist II as a prognostic marker in HCC. Cancer 1994;73: 2464-71.
11. Shapiro AD, Jacobson LJ, Armon ME, et al. Vitamin K deficiency in the new-born infant: prevalence and perinatal risk factor. J Pediatr 1986;109:675-80.
12. Kries R, Gobel U, Maase B. Vitamin K deficiency in the new-born. Lancet 1985;2:728-9.
13. Malia RG, Preston JE, Mitchell VE. Evidence against vitamin K deficiency in normal neonates. Thromb Haemost 1980; 44:159-67.
14. Lane PA, Hathaway WE, Githens JH, Krugman RD, Rosenberg DA. Fatal incranial hemorrhage in a normal infant secondary to vitamin K deficiency. Pediatrics 1983;72:562-4.
15. Friedman PA, Rosenberg RD, Hauschka PV, Fitz-James A. A spectrum of partially caboxylated prothrombins in the plasma samples of coumarin-treated patients. Biochim Biophys Acta 1977;494:271-6.
16. Walker NP, Barlow BA, Atkinson PM. A rapid chromogenic method for the determination of prothrombin precursor in plasma. Am J Clin Pathol 1982;78:770-8.
17. Soulier JP, Gozin D, Lefrere JJ. A new method to assay des-gamma-carboxy-prothrombin. Results obtained in 75 cases of HCC. Gastroenterol 1986;91:1258-62.
18. Lefrere JJ, Conrad J, Mavier P. Coagulation assays as diagnostic markers of HCC. Thromb Haemost 1988;60:468-70.
19. Blanchard RA, Furie BC, Kruger SF, Waneck G, Jorgensen MJ, Furie B. Immunoassays of human prothrombin species which correlate with functional coagulant activities. J Lab Clin Med 1983;101:242-55.
20. Meguro T, Yamada Y. A simple and rapid test for PIVKA-II in plasma. Thromb Res 1982;25:109-14.
21. Widdershoven J, von Munster P, de Abren R, et al. Four methods compared for measuring des-carboxy-prothrombin (PIVKA-II). Clin Chem 1987;33:2074-8.
22. Motohara K, Kuroki Y, Kan H, Endo F, Matsuda J. Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin. Pediatr Res 1985;19:354-7.
23. Amiral J, Grosley M, Plassart V, Mimilla F, Corbel L, Chambrette B. A new monoclonal test for the assay of decarboxyprothrombin (DCP) in hepatocarcinomas. Blood Coagul Fibrinolysis 1990;1:739-40.
24. Church WR, Messier T, Howard PR, Amiral J, Meyer D, Mann KG. A conserved epitope on several human vitamin K-dependent proteins. J Biol Chem 1988;263:6259-67.
25. Amiral J. Coagulation protein C. In: Methods of enzymatic analysis. V. IX proteins and peptides. Weinheim: Bergmeyer, 1986:332-46.
26. Nisonoff A, Wissler FC, Lipman LN, Woernley DL. Separation of univalent fragments from the bivalent rabbit antibody by reduction of disulfide bonds. Arch Biochem Biophys 1960; 89:230-44.
27. Kohler G, Millstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature 1975;256: 495-7.
28. Malhotra OP. Purification and characterisation of dicoumarol-induced prothombins. Barium citrate atypical (7 GLa) prothrombin. Thromb Res 1979;15:427-37.
29. Malhotra OP. Purification and characterisation of dicoumarol-induced prothrombins II. Barium oxalate atypical (5 Gla) variant. Thromb Res 1979;15:439-48.
30. Tuhy PM, Bloom JW, Mann KG. Decarboxylation of bovine prothrombin fragment 1 and prothrombin. Biochemistry 1979;18:5842-58.
31. Bajaj SP, Price PA, Russel WA. Decarboxylation of γ-carboxyglutamic acid residues in human prothrombin. J Biol Chem 1982;257:3726-31.
32. Kuwada M, Katayama K. An improved method for the determination of γ-carboxyglutamic acid in proteins, bone, and urine. Anal Biochem 1983;131:173-9.
33. Malhotra OP. Purification and characterisation of dicoumarol-induced prothrombins. III. Alumina pH 4.6 atypical (2 Gla) variant. Thromb Res 1976;15:449-63.
34. Malhotra OP. Partially carboxylated prothrombins. 1. Comparison of activation properties and purification of 1 and 0 carboxyglutamyl variants. Biochim Biophys Acta 1982;702: 178-84.
35. Liebman HA. Isolation and characterization of a hepatoma-associated abnormal (des-γ-carboxy)prothrombin. Cancer Res 1989;49:6493-7.
36. Olson JA. Recommended dietary intakes (RDJ) of vitamin K in humans. Am J Clin Nutr 1987;45:687-92.